4Hara M,Kai Y,Ikemoto Y.Enhancement by propofol of the gamma-aminobutyric acid A response in dissociated hippoeampal pyramidal neurons of the rat.Anesthesiology,1994,81:988-994.
5Patten D,Foxon GR,Martin KF,et al.An electrophysiological study of the effects of propofol on native neuronal ligandgated ion channels.Clin Exp Pharmacol Physiol,2001,28:451-458.
6Orser BA,Wang LY,Pennefather PS,et al.Propofol modulates activation and desensitization of GABAA receptors in cultured murine hippocampal neurons.J Neurosci,1994,7747-7760.
7Irifune M,Takarada T,Shimizu Y,et al.Propofol-induced anesthesia in mice is mediated by gamma-aminobutyrie acid-A and excitatory amino acid receptors.Anesth Analg,2003,97:424-429.
8Sonner JM,Zhang Y,Stabernack C,et al.GABA(A) receptor blockade antagonizes the immobilizing action of propofol but not ketamine or isoflurane in a dose-relafed manner.Anesth Analg,2003,96:706-712.
9Fukami S,Uchida I,Takenoshita M,et al.The effects of a point mutation of the beta2 subunit of GABA(A) receptor on direct and modulatory actions of general anesthetics.Eur J Pharmacol,1999,368:269-276.
10Jurd R,Arras M,Lambert S,et al.General anesthetic actions in vivo strongly attenuated by a point mutation in the GABA (A) receptor beta3 subunit.FASEB J,2003,17:250-252.
4Lagrew DC. Postpartum hemorrhage:state and national response[J]. Curr Opin Hemato1,2014,21 (6) :528-533.
5Bai J,Sun Q,Zhai H. A comparison of oxytocin and carboprost tromethamine in the prevention of postpartum hemorrhage in high-risk patients undergoing cesarean delivery[J]. Exp Ther Med, 2014,7( 1 ) :46-50.
6Chaudhuri P, Majumdar A. Sublingual misoprostol as an adjunct to oxytocin during cesarean delivery in women at risk of postpar- tum hemorrhage[J]. Int J Gynaecol Obstet,2015,128( 1 ) :48-52.
7Chaudhuri P, Mandal A, Das C, et al. Dosing interval of 24 hours versus 48hours between mifepristone and misoprostol administra- tion for mid -trimester termination of pregnancy[J] . Int J Gy- naecol Obstet,2014,124(2) : 134 - 138.
8Dickinson JE, Jennings BG, Doherty DA. Mifepristone and oral, vaginal, or sublingual misoprostol for second- trimester abor- tion: a randomized controlled trial[J] . Obstet Gynecol, 2014, 123(6):1 162-1 168.
